Skip to main content

UBS Group AG

Position in ANEB — Anebulo Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ANEB

as of Dec 31, 2025 · filed Jan 29, 2026
Position Value
$2,357
+$1,807 QoQ
Shares Held
2,334
+960.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 19 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ANEB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,306,928,575 across 560 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ANEB

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $2,357 2,334
2025-09-30 $550 220
2025-06-30 $132 92
2025-03-31 $1 1
2024-12-31 $42 25
2024-09-30 $1,472 763
2024-03-31 $413 144
2022-12-31 $4,111 1,696
2022-09-30 $7,786 2,781
2022-06-30 $15,126 2,909
2022-03-31 $15,264 2,156
2021-12-31 $3,567 580
2021-09-30 $5,554 848
2021-06-30 $1,595 234